CRISPR Therapeutics AG (CRSP) vs Hims & Hers Health, Inc. (HIMS)
A side-by-side comparison of CRISPR Therapeutics AG and Hims & Hers Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
CRSP
CRISPR Therapeutics AG
$55.26HealthcareDelayed quote: Oct 2, 2026, 3:55 PM EDT
HIMS
Hims & Hers Health, Inc.
$28.91HealthcareDelayed quote: Oct 2, 2026, 3:55 PM EDT
Total return — CRSP vs HIMS
growth of $100 · dividends reinvested · last 7yCRSP +16.3% (+2.2%/yr)HIMS +199.0% (+16.9%/yr)HIMS compounded faster over this window
CRSP HIMS
CRSP vs HIMS: by the numbers
- •HIMS is the larger company ($6.45B vs $5.33B market cap).
- •Both run net losses; HIMS's is the smaller (-5.51% vs -3368.72% net margin).
- •HIMS grew revenue faster over the past five years (67.47% vs 37.32% CAGR).
Metrics side by side
Valuation
| Metric | CRSP | HIMS |
|---|---|---|
| P/S ratio | 397.98 | 2.50 |
| P/B ratio | 3.05 | 19.90 |
| FCF yield | N/A | 1.39% |
Profitability
| Metric | CRSP | HIMS |
|---|---|---|
| Gross margin | -6537.01% | 73.84% |
| Operating margin | -16191.40% | 4.50% |
| Net margin | -3368.72% | -5.51% |
| ROE | -25.83% | -43.83% |
| ROIC | -21.12% | -4.30% |
Growth (annualized)
| Metric | CRSP | HIMS |
|---|---|---|
| Revenue CAGR (5Y) | 37.32% | 67.47% |
| Total return CAGR (5Y) | -13.01% | 32.05% |
Frequently asked
- Which has grown faster, CRSP or HIMS?
- Over the past five years, HIMS grew revenue faster — CRSP at a 37.32% CAGR versus HIMS at 67.47%.
- How have CRSP and HIMS total returns compared?
- Over the past 5 years, CRSP delivered -13.01% and HIMS delivered 32.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CRISPR Therapeutics AG ROEHims & Hers Health ROECRISPR Therapeutics AG operating marginHims & Hers Health operating marginCRISPR Therapeutics AG revenue growthHims & Hers Health revenue growthCRISPR Therapeutics AG free cash flowHims & Hers Health free cash flow
CRISPR Therapeutics AG & Hims & Hers Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.